Crossmark

Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal

Crossref DOI link: https://doi.org/10.1016/j.rppnen.2015.03.002

Published Online: 2025-03-18

Published Print: 2015-11-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Sousa, A.S.

Pereira, A.M.

Fonseca, J.A.

Azevedo, L.F.

Abreu, C.

Arrobas, A.

Calvo, T.

Silvestre, M.J.

Cunha, L.

Falcão, H.

Drummond, M.

Geraldes, L.

Loureiro, C.
Funding

Funding for this research was provided by:

Novartis
License Information

Version of Record valid from 2015-11-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul19

Publication History

Received: 2014-10-30

Accepted: 2015-03-08

Published: 2025-03-18